首页|期刊导航|转化医学杂志|短肽-整蛋白序贯肠内营养支持在慢性阻塞性肺疾病急性发作患者中的应用效果

短肽-整蛋白序贯肠内营养支持在慢性阻塞性肺疾病急性发作患者中的应用效果OA

Application Effect of Short Peptide-Intact Protein Sequential Enteral Nutrition Support in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease

中文摘要英文摘要

目的 探讨短肽-整蛋白序贯肠内营养支持方案在慢性阻塞性肺疾病急性加重(AECOPD)患者中的应用效果.方法 选取2024年1月至2025年12月临汾市中心医院收治的AECOPD患者为研究对象,采用随机数表法将患者分为序贯组(202例)和对照组(202例).对照组给予常规整蛋白型肠内营养剂;序贯组第1~4天给予短肽型肠内营养剂,第5天起转为整蛋白型肠内营养剂.比较两组治疗前后营养代谢指标[血清白蛋白(Alb)、转铁蛋白(TRF)、前白蛋白(PA)]、呼吸与肺功能指标[动脉血二氧化碳分压(PaCO2)、动脉血氧分压(PaO2)、第1秒用力呼气容积(FEV1)、FEV1占预计值百分比(FEV1%pred)]、肠屏障功能指标[血清二胺氧化酶(DAO)、D-乳酸]、临床预后指标及肠内营养相关不良反应.结果 治疗第7天、14天,两组Alb、TRF、PA水平均升高(P<0.05),且序贯组均高于对照组(P<0.05).治疗第14天,两组PaO2、FEV1、FEV1%pred均升高(P<0.05),且序贯组均高于对照组(P<0.05);治疗第14天,两组PaCO2、DAO、D-乳酸水平均降低(P<0.05),且序贯组均低于对照组(P<0.05).序贯组机械通气时间、ICU住院时间、总住院时间均短于对照组(P<0.05),肠内营养相关不良反应发生率低于对照组26.24%vs 36.14%,(P<0.05).结论 短肽-整蛋白序贯肠内营养支持可改善AECOPD患者营养状态和肠屏障功能,促进呼吸功能恢复,缩短康复周期,降低不良反应发生率.

Objective To explore the application effect of short peptide-intact protein sequential enteral nutrition support regimen in patients with acute exacerbation of chronic obstructive pulmonary disease(AECOPD).Methods A total of 404 patients with AECOPD admitted to Linfen Central Hospital from January 2024 to December 2025 were selected as research subjects,and divided into the sequential group(n=202)and the control group(n=202)using the random number table method.The control group was given conventional intact protein enteral nutrition preparation;The sequential group was given short peptide enteral nutrition preparation on days 1 to 4,and switched to intact protein enteral nutrition preparation from day 5 onwards.The nutritional metabolism indexes[serum albumin(Alb),transferrin(TRF),prealbumin(PA)],respiratory and pulmonary function indexes[arterial partial pressure of carbon dioxide(PaCO2),arterial partial pressure of oxygen(PaO2),forced expiratory volume in one second(FEV1),the percentage of FEV1 to the predicted value(FEV1%pred)],intestinal barrier function indexes[serum diamine oxidase(DAO),D-lactic acid],clinical prognosis indexes and enteral nutrition-related adverse reactions were compared between the two groups before and after treatment.Results On the 7th and 14th days of treatment,the levels of Alb,TRF and PA were increased in both groups(all P<0.05),and the levels in the sequential group were all higher than those in the control group(all P<0.05).On the 14th day of treatment,the levels of PaO2,FEV1 and FEV1%pred were increased in both groups(all P<0.05),and were higher in the sequential group than in the control group(all P<0.05);the levels of PaCO2,DAO and D-lactic acid were decreased in both groups(all P<0.05),and were lower in the sequential group than in the control group(all P<0.05).The duration of mechanical ventilation,length of ICU stay and total length of hospital stay in the sequential group were all shorter than those in the control group(all P<0.05),and the incidence of enteral nutrition-related adverse reactions was lower than that in the control group 26.24%vs 36.14%,(P<0.05).Conclusion Short peptide-intact protein sequential enteral nutrition support can improve the nutritional status and intestinal barrier function of patients with AECOPD,promote the recovery of respiratory function,shorten the rehabilitation cycle and reduce the incidence of adverse reactions.

韩彩芳;段冬仙;李静;耿萌;张智霞

临汾市中心医院呼吸与危重症和睡眠医学科,山西 临汾 041000临汾市中心医院呼吸与危重症和睡眠医学科,山西 临汾 041000临汾市中心医院呼吸与危重症和睡眠医学科,山西 临汾 041000临汾市中心医院呼吸与危重症和睡眠医学科,山西 临汾 041000临汾市中心医院呼吸与危重症和睡眠医学科,山西 临汾 041000

慢性阻塞性肺疾病急性加重短肽型肠内营养剂整蛋白型肠内营养剂肠内营养支持

chronic obstructive pulmonary diseaseacute exacerbationshort peptide enteral nutrition preparationintact protein enteral nutrition preparationenteral nutrition support

《转化医学杂志》 2026 (10)

1681-1685,5

山西省卫生健康委员会科研课题计划项目(2021156)

10.3639/j.issn.2095-3097.2026.10.009

评论